C W P. Hopkins < C Warren Olanow < C. A Maurage

Facettes :

List of bibliographic references indexed by C Warren Olanow

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]

Ident.	Authors (with country if any)	Title
000179 (2015)	Daniela Berg [Allemagne] ; Ronald B. Postuma [Canada] ; Charles H. Adler [États-Unis] ; Bastiaan R. Bloem [Pays-Bas] ; Piu Chan [République populaire de Chine] ; Bruno Dubois [France] ; Thomas Gasser [Allemagne] ; Christopher G. Goetz [États-Unis] ; Glenda Halliday [Australie] ; Lawrence Joseph [Canada] ; Anthony E. Lang [Canada] ; Inga Liepelt-Scarfone [Allemagne] ; Irene Litvan [États-Unis] ; Kenneth Marek [États-Unis] ; José Obeso [Espagne] ; Wolfgang Oertel [Allemagne] ; C Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Matthew Stern [États-Unis] ; Günther Deuschl [Allemagne]	MDS research criteria for prodromal Parkinson's disease.
000180 (2015)	Ronald B. Postuma [Canada] ; Daniela Berg [Allemagne] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] ; C Warren Olanow [États-Unis] ; Wolfgang Oertel [Allemagne] ; José Obeso [Espagne] ; Kenneth Marek [États-Unis] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; Glenda Halliday [Australie] ; Christopher G. Goetz [États-Unis] ; Thomas Gasser [Allemagne] ; Bruno Dubois [France] ; Piu Chan [République populaire de Chine] ; Bastiaan R. Bloem [Pays-Bas] ; Charles H. Adler [États-Unis] ; Günther Deuschl [Allemagne]	MDS clinical diagnostic criteria for Parkinson's disease.
000192 (2015)	C Warren Olanow [États-Unis]	Levodopa: effect on cell death and the natural history of Parkinson's disease.
000237 (2015)	Andrew J. Lees [Royaume-Uni] ; Eduardo Tolosa ; C Warren Olanow	Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
000331 (2015)	Karl Kieburtz [États-Unis] ; C Warren Olanow [États-Unis]	Advances in clinical trials for movement disorders.
000374 (2014)	Daniela Berg [Allemagne] ; Ronald B. Postuma [Canada] ; Bastiaan Bloem [Pays-Bas] ; Piu Chan [République populaire de Chine] ; Bruno Dubois [France] ; Thomas Gasser [Allemagne] ; Christopher G. Goetz [États-Unis] ; Glenda M. Halliday [Australie] ; John Hardy [Royaume-Uni] ; Anthony E. Lang [Canada] ; Irene Litvan [États-Unis] ; Kenneth Marek [États-Unis] ; José Obeso [Espagne] ; Wolfgang Oertel [Allemagne] ; C Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Matthew Stern [États-Unis] ; Günther Deuschl [Allemagne]	Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease
000391 (2014)	C Warren Olanow ; Jose A. Obeso	The end of the term.
000422 (2014)	David G. Standaert ; C Warren Olanow ; José A. Obeso	Scientific perspectives.
000437 (2014)	Stanley Fahn [États-Unis] ; C Warren Olanow	Reply to: psychogenic movement disorders: what's in a name?
000480 (2014)	C Warren Olanow [États-Unis] ; Dustin R. Wakeman ; Jeffrey H. Kordower	Peripheral alpha-synuclein and Parkinson's disease.
000544 (2014)	C Warren Olanow [États-Unis] ; Karl Kieburtz ; Fabrizio Stocchi	Initiating levodopa therapy for Parkinson's disease.
000551 (2014)	C Warren Olanow ; Jose A. Obeso	Impact factor for 2013.
000692 (2014)	Stanley Fahn [États-Unis] ; C Warren Olanow	"Psychogenic movement disorders": they are what they are.
000725 (2013)	C Warren Olanow [États-Unis] ; Jose A. Obeso ; Fabrizio Stocchi	The vatican meeting on neuroprotection for Parkinson's disease.
000862 (2013)	C Warren Olanow [États-Unis] ; Patrik Brundin	Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
000873 (2013)	Fabrizio Stocchi [Italie] ; C Warren Olanow	Obstacles to the development of a neuroprotective therapy for Parkinson's disease.
000934 (2013)	Erwan Bézard ; C Warren Olanow ; José A. Obeso	Levodopa-induced dyskinesias in the absence of nigrostriatal degeneration.
000B72 (2012)	C Warren Olanow [États-Unis] ; José A. Obeso	The significance of defining preclinical or prodromal Parkinson's disease.
000B91 (2012)	Manuel Alegre ; Mark Hallett ; C Warren Olanow ; Jose A. Obeso	Technical advances in deep brain stimulation: how far is enough?
000C10 (2012)	C Warren Olanow ; Ole Isacson	Stem cells for Parkinson's disease: advancing science but protecting patients.
000C64 (2012)	Andrew Lees [Royaume-Uni] ; Stanley Fahn ; Karla M. Eggert ; Joseph Jankovic [États-Unis] ; Anthony Lang ; Federico Micheli ; M Maral Mouradian ; Wolfgang H. Oertel ; C Warren Olanow ; Werner Poewe [Autriche] ; Olivier Rascol ; Eduardo Tolosa ; David Squillacote ; Dinesh Kumar	Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "C Warren Olanow" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "C Warren Olanow" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    C Warren Olanow
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024